The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient ...

Three industry veterans bring decades of strategic consultancy experience across the US, EU, and Asia Pacific to better ...

The company's semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid ...

Under the terms of the latest agreement, CDR-Life could receive up to up to $570m in total payments. This includes ...

2. Use shared criteria to guide portfolio choices A transparent, data-driven, decision-making framework helps global and ...

Platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials ...

The drug candidate has been given breakthrough and priority medicines designations from the FDA and EMA respectively ...

But there is also an important R we need, to help maintain our well-being through these turbulent times, and that’s ...

To open up more clinical paths for patients, HCPs need simpler search tools, better access to information and integrated ...

Branded or unbranded? In clinical marketing, this choice shapes how your message lands. Learn how to pick the right strategy ...

The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio ...

Today, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) proudly marks European Laboratory Day, ...